| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.092 | 0.09 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |